Live Quote · OTCNWBOHealthcare· Biotechnology

Northwest Biotherapeutics, Inc.

$0.19 3.83%(+$0.01)
TickerSpark Score
35/100
Weak
20
Valuation
40
Profitability
60
Growth
24
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NWBO research report →

52-Week Range5% of range
Low
$0.18
Current
$0.19
High
$0.37
Company Overviewwww.nwbio.com

About the company

Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform.

CEO
Linda F. Powers
IPO
2001
Employees
25
HQ
Bethesda, MD, US

Price Chart

-24.84% · this period
$0.32$0.25$0.18Jul 02Dec 31Jul 02
Valuation
Market Cap
$312.24M
P/E
-6.23
P/S
208.57
P/B
-7.91
EV/EBITDA
-6.26
Div Yield
0.00%
Profitability
Gross Margin
-44.89%
Op Margin
-3574.01%
Net Margin
-2931.73%
ROE
62.41%
ROIC
-129.42%
Growth & Income
Revenue
$1.38M · -0.29%
Net Income
$-61,477,000 · 26.62%
EPS
$-0.04 · 38.48%
Op Income
$-59,914,000
FCF YoY
20.27%
Performance & Tape
52W High
$0.37
52W Low
$0.18
50D MA
$0.21
200D MA
$0.23
Beta
-0.63
Avg Volume
3.32M

Get TickerSpark's AI analysis on NWBO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Aug 29, 24BOYNTON ALTON Lother1,000,000
Aug 9, 24BOSCH MARNIX Lother3,000,000
Aug 8, 24BOYNTON ALTON Lother1,000,000
Jul 26, 24MALIK NAVIDsell657,895
Nov 16, 23MALIK NAVIDsell125,000
Nov 17, 23MALIK NAVIDsell150,000
Nov 17, 23MALIK NAVIDsell295,000
Apr 3, 23BOSCH MARNIX Lother119,355
Apr 4, 23BOYNTON ALTON Lother6,794,191
May 26, 22BOYNTON ALTON Lother4,900,000
Coverage · NWBO

Our NWBO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NWBO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NWBO report →
Internal Compare

Similar companies

Peers in the same neighborhood.